TherapeuticsMD reported $-1.64M in EBITDA for its fiscal quarter ending in September of 2023.





Ebitda Change Date
AbbVie USD 6.91B 3.22B Jun/2026
Alterity Therapeutics Limited AUD -7.72M 2.99M Jun/2023
Cipla INR 13.88B 154.2M Sep/2026
Clal Biotechnology ILS -5.3M 2.09M Dec/2022
Compugen USD -8.84M 180K Jun/2026
CSL USD 3.13B 1.17B Dec/2025
Grifols EUR 482.04M 7.04M Sep/2025
Novo Nordisk DKK 37.36B 31.84B Jun/2026
Pfizer USD 6.36B 350M Sep/2026
TherapeuticsMD USD -1.64M 700K Sep/2023